Apart from Na(+),K(+)-
ATPase, a second
sodium pump, Na(+)-stimulated, K(+)-independent
ATPase (
Na(+)-ATPase) is expressed in proximal convoluted tubule of the mammalian kidney. The aim of this study was to develop a method of
Na(+)-ATPase assay based on the method previously used by us to measure Na(+),K(+)-
ATPase activity. The
ATPase activity was assayed as the amount of
inorganic phosphate liberated from
ATP by isolated microsomal fraction.
Na(+)-ATPase activity was calculated as the difference between the activities measured in the presence and in the absence of 50 mM NaCl.
Na(+)-ATPase activity was detected in the renal cortex (3.5 +/- 0.2 mumol
phosphate/h per mg
protein), but not in the renal medulla.
Na(+)-ATPase was not inhibited by
ouabain or an H(+),K(+)-
ATPase inhibitor,
Sch 28080, but was almost completely blocked by 2 mM
furosemide.
Leptin administered intraperitoneally (1 mg/kg) decreased the Na(+),K(+)-
ATPase activity in the renal medulla at 0.5 and 1 h by 22.1% and 27.1%, respectively, but had no effect on
Na(+)-ATPase in the renal cortex. Chronic hyperleptinemia induced by repeated subcutaneous
leptin injections (0.25 mg/kg twice daily for 7 days) increased cortical Na(+),K(+)-
ATPase, medullary Na(+),K(+)-
ATPase and cortical
Na(+)-ATPase by 32.4%, 84.2% and 62.9%, respectively. In rats with dietary-induced
obesity, the Na(+),K(+)-
ATPase activity was higher in the renal cortex and medulla by 19.7% and 34.3%, respectively, but
Na(+)-ATPase was not different from control. These data indicate that both renal Na(+)-dependent
ATPases are separately regulated and that up-regulation of
Na(+)-ATPase may contribute to Na(+) retention and arterial
hypertension induced by chronic hyperleptinemia.